Google Search

Search

Already a Member ?

Best Business Opportunities in Eritrea, Africa- Identification and Selection of right Project, Thrust areas for Investment, Industry Startup and Entrepreneurship

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 11 of 35 | Total 346 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 34 35   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

PHARMACEUTICAL PELLETS AND GRANULES - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

The word “Pellet” has been used to describe a variety of systematically produced, geometrically defined agglomerates obtained from diverse starting materials utilizing different processing conditions. Pellets range in size, typically, between 0.5 – 1.5 mm, though other sizes could be prepared. Pellets are for pharmaceutical purposes and are produced primarily for the purpose of oral controlled-release dosage forms having gastro resistant or sustained-release properties or the capability of site-specific drug delivery. For such purposes, coated pellets are administered in the form of hard gelatin capsules or disintegrating tablets that quickly liberate their contents of pellets in the stomach. As drug-delivery systems become more sophisticated, the role of pellets in the design and development of dosage forms is increasing. Formulation of drugs in multiple-unit dosage forms, such as coated pellets filled in capsules or compressed into tablets, offers flexibility as to target-release properties. The safety and efficacy of the formulation is higher than that of other dosage forms. Solid dosage formulation and design usually involves a serious of compromises, since producing the desired properties frequently involves competing objectives. The correct selection and balance of excipients materials and processes in a solid dosage formulation, to achieve the desired response is not in practice easy to achieve. Pellets are of a great interest to the pharmaceutical industry for a variety of reasons. Palletized products not only offer flexibility in dosage form design and development, but are also utilized to improve the safety and efficiency of bioactive agents. Pellets range in size, between 0.5 to 1.5. USES & APPLICATION Pellets/ granules may have varied applications in varied industries. It just requires an innovative bend to use it to derive maximum profitability. The smooth surface & the uniform size of the pellets allow uniform coating not only for each pellet but also from batch to batch. Highlighted below are some of the few instances where smooth surfaced uniform pellets are being successfully used: Improved appearance of the products. Coating of pellets can be done with different drugs to enable a controlled release rate. In case of immediate Release Products larger surface area of pellets enables better distribution. Chemically incompatible products can be formed into pellets & delivered in a single dose by encapsulating them. In the chemical industries it is used to avoid powder dusting. Varied applications are possible in the pellet form. Eg: sustained release. Pellets ensure improved flow properties, and flexibility in formulation development and manufacture. The coating material may be colored with a dye material so that the beads of different coating thickness will be darker in color and distinguishable from those having fewer coats. The beads or granules of different thickness of coatings are blended in the desired proportions to give the desired effect. The thickness of the coat on the pellets dictates the rate at which the drug/ contents are released from the coated particles. A smooth surface of the pellets & uniform coating thickness for each pellet. By selecting the proper formulation, processing conditions and processing equipment it is possible to attain smooth surfaced & uniform pellets. The most common advantages of pelletization are: Improved appearance of the product and the core is pharmaceutically elegant. Pelletization offers flexibility in dosage form design and development, Pellets are less susceptible to dose dumping, It reduces localized concentration of irritative drugs, It improves safety and efficacy of a drug, Pellets offer reduced variation in gastric emptying rate and transit time, Pellets disperse freely in G.I.T. and invariably maximize drug absorption and also reduce peak plasma fluctuation, Pellets ensure improved flow properties in formulation development. MARKET SURVEY The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. However, the Indian industry, valued at USD 17 bn in represented just over 1% of the global pharmaceutical industry (USD 1700 bn) in value terms. The domestic market is estimated at Rs 680 bn. According to the Federation of Indian Chambers of Commerce and Industry (FICCI), another apex industry association, there are some 6,000 firms engaged in the sector. In terms of revenue gene-ration, there are 100 big companies (including subsidiaries of MNCs) each with sales of at least USD 650,000, 200 medium size companies with sales ranging between USD 210,400 and USD 650,000; and 5700 small companies with sales of less than USD 210,400. Because many of these companies focus on producing similar generic or same drugs, the industry is characterized by fierce competition and high volumes, razor-thin profit margins, overcapacity, and declining prices. The growth has been driven by many factors, such as legislative reforms, growth in contract manufacturing and outsourcing, value added foreign acquisitions and joint ventures and India's acumen and expertise in reverse engineering of patented drug molecules. India has, in the meantime, been trying to comply with the World Trade Organization's Trade Related Intellectual Property Agreement (TRIPs) obligations. India is now among the top five pharmaceutical emerging markets. The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15 per cent over the last five years and has significant growth opportunities. The Indian pharmaceutical sector is expected to grow five-fold to reach Rs 5 lakh crore (US$ 91.45 billion) by 2020, as per Dr A J V Prasad, Joint Secretary, Department of Pharmaceuticals (DoP). The industry, particularly, has been the front runner in a wide range of specialties involving complex drugs' manufacture, development, and technology. With the advantage of being a highly organized sector, the number of pharmaceutical companies are increasing their operations in India. PRESENT MANUFACTURERS Abbott India Ltd. Anglo-French Drugs & Inds. Ltd. Biological E. Ltd. Boehringer Mannheim India Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Chemcel Biotech Ltd. Cosme Farma Laboratories Ltd. Fermenta Biotech Ltd. H P M Industries Ltd. Indian Drugs & Pharmaceuticals Ltd. Inventia Healthcare Pvt. Ltd. M S T C Ltd. Mayo (India) Ltd. Neo Corp Intl. Ltd. Northern Minerals Ltd. Pharmacia Healthcare Ltd. Rhyme Organics & Chemicals Ltd. Sandoz (India) Ltd. Sanofi India Ltd. Sarvodaya Labs Ltd. Shiv Herbal Research Laboratory Ltd. Sidmak Laboratories (India) Pvt. Ltd. Smith Stanistreet Pharmaceuticals Ltd. Stanpacks (India) Ltd. T T K Healthcare Ltd. Varun Polymol Organics Ltd. Virgo Polymers (India) Ltd. Wallace Pharmaceuticals Ltd.
Plant capacity: 600 Kgs/DayPlant & machinery: Rs. 208 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 547 Lakhs
Return: 26.86%Break even: 63.39%
Add to Inquiry Add to Inquiry Basket

PHARMACEUTICAL UNIT (Automatic Plant of Tablet and Capsule) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Indian Pharma Industry is playing a key role in promoting and sustaining development in the vital field of medicines, besides this it boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world. The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market, with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on the international market. Market Survey The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. However, the Indian industry, valued at USD 17 bn in represented just over 1% of the global pharmaceutical industry in value terms. The domestic market is estimated at Rs 680 bn. According to a study by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of USD 25 bn (Rs 1200 bn) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing. Incidentally, according to another report by Associated Chamber of Commerce (ASSOCHAM) in India, the market is estimated to grow to more modest level of USD 9.5 bn in 2010). India has the world's third largest active pharmaceutical ingredients (API) for the industry valued at a little less than USD 2 bn. Top 5 API producers account for approximately 6.5 %. The leading APIs are anti-infective, gastrointestinal, cardiovascular and respiratory drugs. However, India's pharmaceutical industry might witness some decline in the number of smaller companies that either leave the market or are acquired by larger Indian or foreign companies. Since 2000, a number of smaller Indian pharmaceutical companies have, in fact, been acquired by larger companies. These cases include, among the more notable ones, Wockhardt's acquisition of Merind and Tata Pharma; Ranbaxy's purchase of Crosland; Nicholas Piramal's acquisition of Roche etc. The Indian firms produce nearly 60,000 generic brands in 60 therapeutic categories and between 350 and 400 bulk drugs. India's drug market consists mainly of second and third generation drugs no longer subject to patent protection in the developed world. Although India is the world's leading producer of generic drugs, its annual per capita consumption of pharmaceuticals has been among the lowest placed approximately at USD 4.50 per person as compared to USD 820 in the United States and USD 13 in China. The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. The key categories driving growth are the traditionally largest segment - anti-infective and gastro-intestinal, drugs, which expanded by 22% and 19% respectively. Fast sales growth is also visible in categories like respiratory (18%), cardiac (14%), neurology (20%) and anti-diabetic (19%). Anti-TB is the only category that has seen a decline in value and volume terms. The number of product launches exceeds 2,000 annually. Both MNC and Indian companies are implementing strategies which will help them to benefit from and cope with the developing patent regime. Global pharma companies are increasingly exploring low cost option to outsource research and manufacturing, because of emerging slow-down in patented drug sales and high cost of R&D. Indian pharmaceutical companies are in various stages of new drug discoveries. They have been scouting for global partners to help them in their goal. However, companies like Dr Reddy's Laboratories, Wockhardt’s, Glen mark Pharmaceuticals, Ranbaxy Laboratories, Orchid Chemicals and Lupin need financial and technical support from foreign pharmaceutical players to take their new drugs to the global market. Dr. Reddy's Laboratory (DRL) recently announced the beginning of Phase III clinical trials of its anti-diabetic drug Balagliatzone. Co-developed with Danish firm Rheoscience, the successful completion of the trial could give India its first intellectual property from the pharma sector. India has the highest number of (US Food and Drug Administration) USFDA approved manufacturing facilities outside the US and this puts India in good position to export to regulated markets. The major players in the country are: Aanjaneya Lifecare Ltd. Aashi Industries Ltd. Abbott India Ltd. Advik Laboratories Ltd. Aesculapius Remedies Ltd. Ajanta Pharma Ltd. Albert David Ltd. Alkem Laboratories Ltd. Alpa Laboratories Ltd. Ambalal Sarabhai Enterprises Ltd. Amee Cosmo Pharma Ltd. American Remedies Ltd. Amstrin Healthcare Ltd. Anan Drug & Chem Ltd. Andre Laboratories Ltd. Anglo-French Drugs & Inds. Ltd. Ankur Drugs & Pharma Ltd. Anmol Drugs & Pharmaceuticals Ltd. Anuh Pharma Ltd. Apex Laboratories Ltd. Apple Laboratories Ltd. Armour Chemicals Ltd. Arvind Remedies Ltd. Astrazeneca Pharma India Ltd. Astron Drugs & Inds. Ltd. Aurobindo Pharma Ltd. Aventis Pharma Ltd. B D H Industries Ltd. Bafna Pharmaceuticals Ltd. Bal Pharma Ltd. Basav Chem Ltd. Bassein Drugs Ltd. Beem Healthcare Ltd. Bengal Immunity Ltd. Beryl Drugs Ltd. Bharat Parenterals Ltd. Bharat Serums & Vaccines Ltd. Biddle Sawyer Ltd. Bio-Ethicals Pharma Ltd. Biocon Biopharmaceuticals Pvt. Ltd. Biocon Ltd. Biofil Chemicals & Pharmaceuticals Ltd. Biological E. Ltd. Blue Cross Laboratories Ltd. Boehringer Mannheim India Ltd. Brabourne Enterprises Ltd. Bravo Healthcare Ltd. Brawn Biotech Ltd. Burroughs Wellcome (India) Ltd. Cadila Healthcare Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Caplin Point Laboratories Ltd. Caryl Laboratories Ltd. Casil Industries Ltd. Celestial Biolabs Ltd. Centaur Pharmaceuticals Pvt. Ltd. Cepham Organics Ltd. Cepham Pharmaceuticals Ltd. Chemech Laboratories Ltd. Chemosyn Ltd. Ciba Ckd Biochem Ltd. Claris Lifesciences Ltd. Colinz Laboratories Ltd. Combat Drugs Ltd. Concept Pharmaceuticals Ltd. Concord Biotech Ltd. Concord Drugs Ltd. Coral Laboratories Ltd. Core Laboratories Ltd. Cosme Farma Laboratories Ltd. Cosme Pharma Ltd. Creative Health Care Pvt. Ltd. Croslands Research Laboratories Ltd. Croydon Chemical Works Ltd. Curewell (India) Ltd. Damania Pharma Ltd. Deepharma Laboratories Ltd. Deepharma Ltd. Dey'S Medical Stores Mfg. Ltd. Dishman Pharmaceuticals & Chemicals Ltd. Dolphin Laboratories Ltd. Dr. Reddy'S Laboratories Ltd. Druid Pharma Ltd. Dujohn Laboratories Ltd. Dumex Ltd. Eaco Labs Ltd. Earnest Healthcare Ltd. East India Pharmaceutical Works Ltd. Ebers Pharmaceuticals Ltd. Elder Health Care Ltd. Elder Pharmaceuticals Ltd. Elder Projects Ltd. Elvina Pharmaceuticals Ltd. Emaai Pharma Ltd. Emcure Pharmaceuticals Ltd. Endo Labs Ltd. Entod Pharmaceuticals Ltd. Esskay Pharmaceuticals Ltd. Ethnor Ltd. Eupharma Laboratories Ltd. Everest Organics Ltd. Evid & Co. Chemicals Ltd. F D C Ltd. Fine Drugs & Chemicals Ltd. Flamingo Pharmaceuticals Ltd. Fredun Pharmaceuticals Ltd. Fresenius Kabi Oncology Ltd. Fulford (India) Ltd. Geno Pharmaceuticals Ltd. Gentech Laboratories Ltd. Geoffrey Manners & Co. Ltd. German Remedies Ltd. Glaxosmithkline Pharmaceuticals Ltd. Glen mark Exports Ltd. Glen mark Generics Ltd. Glen mark Laboratories Ltd. Glen mark Pharmaceuticals Ltd. Global Remedies Ltd. Goa Antibiotics & Pharmaceuticals Ltd. Group Pharmaceuticals Ltd. Guardian Health Care Ltd. Gufic Biosciences Ltd. Gujarat Inject Ltd. Gujarat Terce Laboratories Ltd. Gujarat Themis Biosyn Ltd. H O D Laboratories Ltd. Hab Pharmaceuticals & Research Ltd. Haffkine Ajintha Pharmaceuticals Ltd. Hallmark Healthcare Ltd. Harleystreet Pharmaceuticals Ltd. Health Care Ltd. Hexone Pharmaceuticals Ltd. Hindustan Max-Gb Ltd. Hub Pharmaceuticals Pvt. Ltd. I D P L (Tamil Nadu) Ltd. Icon Biopharma & Healthcare Ltd. Icpa Health Products Ltd. Idma Laboratories Ltd. Ind-Swift Laboratories Ltd. Ind-Swift Ltd. India Infusion Ltd. Indian Drugs & Pharmaceuticals Ltd. Indoco Healthcare Ltd. Indoco Remedies Ltd. Indon Healthcare Ltd. Innotech Pharma Ltd. Intas Pharmaceuticals Ltd. Intercare Limited Intercare Ltd. International Drug Co. Ltd. Inventia Healthcare Pvt. Ltd. Inwinex Pharmaceuticals Ltd. Ipca Laboratories Ltd. Ivee Injectaa Ltd. J B Chemicals & Pharmaceuticals Ltd. J K Pharmachem Ltd. Jagsonpal Exports India Pvt. Ltd. Jagsonpal Pharmaceuticals Ltd. Jenburkt Pharmaceuticals Ltd. Jilichem Laboratories (India) Ltd. John Wyeth (India) Ltd. Johnson & Johnson Ltd. Kabra Drugs Ltd. Kappac Pharma Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd. Kee Pharma Ltd. Kilitch Drugs (India) Ltd. Konkan Capsules Ltd. Krebs Biochemicals & Inds. Ltd. Labinduss Ltd. Lekar Healthcare Ltd. Lekar Pharma Ltd. Lincoln Pharmaceuticals Ltd. Liva Healthcare Ltd. Lordvin Labs Ltd. Lupin Laboratories Ltd. Lupin Ltd. Lyka B D R International Ltd. Lyka Labs Ltd. Lympha Laboratories Ltd. M J Pharmaceuticals Ltd. Macleods Pharmaceuticals Ltd. Maharashtra Antibiotics & Pharmaceuticals Ltd. Makers Laboratories Ltd. Maneesh Pharmaceuticals Ltd. Manipur State Drugs & Pharmaceuticals Ltd. Marck Biosciences Ltd. Mars Life Sciences Ltd. Martin & Harris Laboratories Ltd. Max India Ltd. Mayank & Lili Pharma Ltd. Mayo (India) Ltd. Mcneil & Argus Pharmaceuticals Ltd. Medicamen Biotech Ltd. Medispan Ltd. Medley Pharmaceuticals Ltd. Meghdoot Chemicals Ltd. Meher Pharma (India) Ltd. Merck Ltd. Mercury Laboratories Ltd. Mercury Phytochem Ltd. Merind Ltd. Mesco Pharmaceuticals Ltd. Metropolitan Overseas Ltd. Micro Labs Ltd. Monarch Laboratories Ltd. Morepen Laboratories Ltd. Mount Mettur Pharmaceuticals Ltd. N B Z Pharma Ltd. N R Jet Enterprises Ltd. Natco Pharma Ltd. Nem Organics Ltd. Neon Laboratories Ltd. Nestor Pharmaceuticals Ltd. Neulife Laboratories Ltd. Nirma Ltd. Nitya Laboratories Ltd. Novartis India Ltd. Novus Pharmaceuticals Ltd. Om Pharmaceuticals Ltd. Omega Biotech Ltd. Omega Laboratories Ltd. Onco Therapies Ltd. Opec Innovations Ltd. Orchid Chemicals & Pharmaceuticals Ltd. Organon (India) Ltd. Ozone Pharmaceuticals Ltd. P C I Chemicals & Pharmaceuticals Ltd. Paam Pharmaceuticals (Delhi) Ltd. Panacea Biotec Ltd. Parabolic Drugs Ltd. Paras Pharmaceuticals Ltd. Parke-Davis (India) Ltd. Penam Laboratories Ltd. Perk Pharmaceuticals Ltd. Pfimex Pharmaceuticals Ltd. Pfizer Ltd. Phaarmasia Ltd. Phar-East Laboratories Ltd. Pharmacia Healthcare Ltd. Pharmaids Pharmaceuticals Ltd. Pharmax Corporation Ltd. Pharmed Ltd. Phyto Specialities Pvt. Ltd. Plethico Pharmaceuticals Ltd. Procter & Gamble Hygiene & Health Care Ltd. Quality Pharmaceuticals Ltd. R P G Life Sciences Ltd. Rajasthan Drugs & Pharmaceuticals Ltd. Rajat Pharmachem Ltd. Ranbaxy Drugs Ltd. Ranbaxy Laboratories Ltd. Raptakos, Brett & Co. Ltd. Ravish Infusions Ltd. Reckitt Benckiser (India) Ltd. Rekvina Laboratories Ltd. Resonance Specialties Ltd. Rhone-Poulenc (India) Ltd. Rolex Pharmaceuticals Ltd. Rosemount Pharma India Ltd. Rubra Medicaments Ltd. Rupal Chemical Inds. Ltd. Rusan Pharma Ltd. S A M Biotech Ltd. Saket Projects Ltd. Sandoz (India) Ltd. [Amalgamated] Sanjeevanee Pharmaceuticals Ltd. Sanjivani Paranteral Ltd. Sanofi-Synthelabo (India) Ltd. Sarabhai Piramal Pharmaceuticals Pvt. Ltd. Sarala Pharmaceuticals Ltd. Sarthi Pharmaceuticals Ltd. Sarvodaya Labs Ltd. Schering-Plough (India) Pvt. Ltd. Senbo Industries Ltd. Shalina Laboratories Pvt. Ltd. Sharvani Pharmaceuticals Ltd. Shiv Herbal Research Laboratory Ltd. Sidmak Laboratories (India) Pvt. Ltd. Sigma Laboratories Ltd. Smith Stanistreet Pharmaceuticals Ltd. Smithkline Beecham Pharmaceuticals (India) Ltd. [Amalgamated] Solumiks Herbaceuticals Ltd. Sri Chakra Remedies Ltd. Sri Krishna Drugs Ltd. Sri Krishna Pharmaceuticals Ltd. Strides Arcolab Ltd. Sun Pharmaceutical Inds. Ltd. Surya Pharmaceutical Ltd. Sustime Pharma Ltd. Suyog Pharmaceuticals Pvt. Ltd. Swega Laboratories Ltd. Swet-Chem Antibiotics Ltd. Syncom Formulations (India) Ltd. Syncom Healthcare Ltd. T K Healthcare Ltd. Tablets (India) Ltd. Tamilnadu Dadha Pharmaceuticals Ltd. Targof Pure Drugs Ltd. Taulis Pharma Ltd. Teem Laboratories Ltd. Themis Medicare Ltd. Tonira Pharma Ltd. Torrent Pharmaceuticals Ltd. Toshvin Industries Ltd. Trans Medicare Ltd. Travel Co. In Pvt. Ltd. Troika Pharmaceuticals Ltd. Twilight Litaka Pharma Ltd. U S V Ltd. Uni-Sankyo Ltd. Uni-Ucb Ltd. Unibios Laboratories Ltd. Unichem Laboratories Ltd. Unicorn Pharmaceuticals (India) Ltd. Unimark Remedies Ltd. Unimed Investments Ltd. Unimed Technologies Ltd. Unique Pharmaceutical Laboratories Ltd. Universal Generics Ltd. Universal Pharmaceuticals Ltd. Unjha Formulations Ltd. Vellanova Pharmaceuticals Ltd. Venkat Pharma Ltd. Veronica Laboratories Ltd. Vista Pharmaceuticals Ltd. Vita Biopharma Pvt. Ltd. Vysali Pharmaceuticals Ltd. Wallace Pharmaceuticals Ltd. Wander Pvt. Ltd. Warren Pharmaceuticals Ltd. Welcure Drugs & Pharmaceuticals Ltd. White Way Products (Pharma) Ltd. Win-Medicare Pvt. Ltd. Wintac Ltd. Wockhardt’s Ltd. Wyeth Laboratories Ltd. Wyeth Ltd. Yogi Healthcare Ltd. Zenith Health Care Ltd. Zenotech Laboratories Ltd. Zillion Pharmachem Ltd. Zim Laboratories Ltd. Zuventus Healthcare Ltd. Zydus Animal Health Ltd. Zydus Pathline Ltd.
Plant capacity: 117 Lakhs Nos. /annumPlant & machinery: Rs. 125 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 1339 Lakhs
Return: 43.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

Packaged Drinking Water - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Water is the necessity of our daily life, it’s so important for us that we need clean, safe and sanitary water every day, and usually there’s a more strict inspection standard in the more advanced country. Potable spring waters containing, sulphur, iron, magnesium and other mineral salts occurring in certain regions are claimed to be beneficial to human metabolism. There are two kinds of drinking water in the market. One is the natural water, which is called mineral water. The other is processed water coming from underground or from the pipe of water plant, which is called R.O. water, space water or pure water. Mineral water comes from natural springs. It contains a lot of various kinds of chemical goods such as potassium, magnesium and calcium, which are healthy to our body. After the water is filtered and sterilized properly, it’s our first choice to use it. However, the shortcoming is that the source of mineral water is limited. On the other side, pure water doesn’t contain any nutrition, but it’s easy to be obtained and very clean after being processed. It tastes good with PH value 5-7?that’s the reason why people like it very much. Pure water is processed through different stages of a filter system such as sand, carbon, and Reversed Osmosis System. The water is passed from 5 micron through 1 to 0.2 micron filter. After that, pure water can be filtered to remove harmful materials with an efficiency of 96%. Uses Mineral water is bottled under very hygienic conditions under strict quality control before being marketed. Its major use is in five star Hotels and Hospitals where good quality pure water is required for potable purposes. It is marketed at places and regions where hygienic drinking water is not freely available. Market Survey Bottled Water Bottled water industry, colloquially called, the mineral water industry, is a symbol of a new lifestyle and health-consciousness emerging in India. While a large segment of the population is struggling to get access to potable water supply, a new generation - especially in the urban areas - is getting accustomed to bottled water paying handsome prices. The total size of the bottled water market in India is estimated at Rs 20 bn. What is amazing is that people are prepared to pay Rs 10 or more for a litre of 'simple' water - especially when the cost of material input is negligible. The cost of packaging can be as high as 15% to 35% of the price of the product. In bottled water market, the cost of entry and the cost of exit is low. One does not require much equipment to make bottled water. The bottled water market is growing at a rapid rate of around 20% a year (down from 50 to 60%). At this growth rate, the market is estimated to overtake the soft drinks market soon. Multi-nationals Coca-Cola, Pepsi, Nestle and others are trying to grab a significant share of the market. There are more than 1800 brands in the unorganized sector. The small players account for nearly 19% of the total market. Nevertheless, per capita consumption of bottled water in India is less than half a litre per year, compared to 111 litres in France and 45 litres in the US. The consumption of smaller packs (500 ml) has increased perceptibly by around 140%. Even school children are carrying the 500-ml packs in their school-bags. The 20 litre jars have found phenomenal acceptance in households and in work places. The growth trends in packaged drinking water and a growing demand is indicative of the fact that water and its variants will be the single largest beverage category, growing and becoming at least 20 times of the current market size within the next 10-12 years. The BIS certification was made mandatory for the segment from April 2001. The bottled water was classified as food and has been brought under the Prevention of Food Adulteration Act. The producers have to adhere to rules pertaining to colour, odour, taste, turbidity, total dissolved solids and aerobic microbial count. Few Major Players are as under:- Ajay Enterprises Ltd. Akash Housing Ltd. [Merged] Aradhana Snack Foods Co. Bikaji Marketing Ltd. Bisleri International Pvt. Ltd. Durgapur Projects Ltd. G E I Foods Ltd. Golden Anchor Pvt. Ltd. Jagatjit Industries Ltd. Keventer Agro Ltd. Mohan Meakin Ltd. Mount Everest Mineral Water Ltd. N E P C Agro Foods Ltd. Nuway Organic Naturals India Ltd. Orient Beverages Ltd. Parle Bisleri Pvt. Ltd. [Merged] Parle International Pvt. Ltd. Pepsico India Holdings Pvt. Ltd. Pondicherry Agro Service & Inds. Corp. Ltd. Rose Valley Inds. Ltd. Sparkle Foods Ltd. Sri Sarvaraya Sugars Ltd. Surat Beverages Ltd. Vaarad Ventures Ltd. Vijay Shanthi Builders Ltd.
Plant capacity: 210 Lakhs Nos. /annumPlant & machinery: Rs. 719 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 1736 Lakhs
Return: 25.00%Break even: 56.00%
Add to Inquiry Add to Inquiry Basket

Copper Sulphate - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Layout

Copper (II) Sulfate is a chemical compound with the formula CuSO4. It occurs in nature as mineral hydrocyanite. It is gray to white and has rhombic crystal morphology. It decomposes to green basic copper (II) sulphate at 340 deg C and at 600-650 deg C it decomposes to copper oxide. It is generally prepared by controlled heating of Copper Sulphate Pent-hydrate, CuSO4.5H2O. Copper sulphate term is generally used to describe pent hydrate compound of copper sulphate which is also known as blue stone, blue vitriol etc. It is best known and the most widely used of the copper salts. Indeed it is often the starting raw material for the production of many of the other copper salts. Today the world's consumption is around 250,000 tons per annum of which it is estimated that approximately three-quarters are used in agriculture, principally as a fungicide. Uses & Application Anhydrous Copper sulphate has limited commercial use. • It is used as a desiccant for removing water from organic solvents. • It acts as a sensitive indicator of the presence of moisture in organic solvents. Copper sulphate pentahydrate is a very versatile chemical with as extensive a range of uses in industry. • It is used as an algaecide, an herbicide in irrigation and municipal water treatment systems, and as a molluscicide, a material used to repel and kill slugs and snails. • The metal industry uses large quantities of copper sulphate as an electrolyte in copper refining, for copper coating steel wire prior to wire drawing and in various copper plating processes. • The mining industry employs it as an activator in the concentration by froth flotation of lead, zinc, cobalt and gold ores. • The printing trade takes it as an electrolyte in the production of electrotype and as an etching agent for process engraving. • The paint industry uses it in anti-fouling paints and it plays a part in the coloring of glass. • Copper sulphate is a fungicide used to control bacterial and fungal diseases of fruit, vegetable, nut and field crops. It is used in combination with lime and water as a protective fungicide, referred to as Bordeaux mixture, for leaf application and seed treatment. • Copper deficiency in plants or animals can be corrected very simply either by applying 50 kg copper sulphate per hectare in the form of a fertilizer before sowing or by spraying the foliage of the young cereal plants. Market Survey The Market Survey on Copper Sulphate is of topical interest in the sense that copper is important metal used in India from ancient times. In fact, one age of human civilization is named after copper. Copper is also used in the alloy form as brass and bronze because of the added advantages. Copper was a scarce metal with respect to India but recent setting up of copper smelters has entirely changed the scenario of copper production/availability in the country. However, these copper smelters, except that of HCL, are producing copper based on the imported concentrates. This has opened a new path for the chemical manufacturing companies for producing copper based chemicals in the country. With numerous copper mines in the country, Copper compounds manufacturing has taken a good shot in last few years. Many Companies are setting their projects at different places in India. They produce environment friendly copper sulphate fertilizer, Copper Sulphate Electroplating Grade, Copper Sulphate Feed grade having 98% Copper content. Copper sulphate is widely used as fungicide in agricultural field. Therefore demand of copper sulphate directly depends upon the usage and development of agriculture in a country. In India, the total installed annual capacity of 43 technical grades of pesticides and fungicide is estimated at 148,000 tonnes of which only four grades (Mancozab 20,700 tonnes, Monocrotophos 14,000 tonnes, Malathion 11,800 tonnes and Endo-sulphan 10,100 tonnes) account for over 38% of the aggregate installed capacities. ? India is one among the most dynamic generic pesticides & fungicides manufacturing countries. And yet, India's own average consumption of it is low, below 500 gms per ha. Crop protection has assumed special importance since the food grains demand in the country is supposed to reach an estimated 343 mn tonnes by 2020. The agrochemical industry allocates an average of about 10% of its total sales turnover for research and development. This amounts to Rs 3.5-4.0 bn. The agrochemical industry is spread over around 200 large and medium sized manufacturers and 600 formulators producing about 60 technical grades of pesticides. Other important players in the sector include 10 multinational companies operating for quite some time. While the organized sector contributes 55% to the industry's output, the small scale sector makes up for the balance. The Indian industry has been focusing on integrated crop management (ICM), increasing exports of genuine pesticides & fungicide and concentrating on farmer-friendly activities. With the global market rising, there are encouraging prospects for the Indian industry. The pesticide industry is targeting a 10% share of global pesticides market and has been working on the ICM program to introduce safer applications, spray devices and crop protection through balanced use of biological and chemical pesticides. The exports cover pesticide intermediates. Pesticides and fungicide exports from India were growing at the rate of 15% and are expected to witness a more accelerated growth. Demand of copper sulphate is increasing rapidly for its use as a natural growth stimulant in animals, as well as in prevention of E.coli and listeria. The food-grade Copper Sulfate industry is a $1.2 billion industry growing at approximately 15% per year.
Plant capacity: 600 Nos. /annumPlant & machinery: 43 Lakhs
Working capital: -T.C.I: Cost of Project: 238 Lakhs
Return: 24.00%Break even: 60.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

It is an instrument which is used for injecting any liquid into the body of human beings or of animals. These syringes are used for injecting the medicine into the body or into the nerve of the body which are not possible to take in through mouth or takes much time in mixing with blood. A syringe is a simple piston pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (the barrel), allowing the syringe to take in and expel a liquid or gas through an orifice at the open end of the tube. The open end of the syringe may be fitted with a hypodermic needle, a nozzle, or tubing to help direct the flow into and out of the barrel. The constantly increasing use of Disposable Syringes made of plastic Material indicates its importance, which is based mainly on the advantages it offers regarding cost and hygienic applications. Due to their availability is sterilized condition, ready to use and cost effectiveness, disposable syringes are fast replacing the age-old glass syringes. Disposable syringes are mostly injection moulded from polypropylene. Syringes are available in sizes of 1ml, 2ml, and 10ml, in a variety of designs and consist of either two or three components in their material of construction. The number and size of injection moulding machines required depends upon syringe construction, number of mould cavities and annual production. Uses & Applications Disposable syringes commonly are used in modern medicine for the injection of drugs and vaccines or for the extraction of blood. Among the common uses of disposable syringes are the injecting of insulin by a diabetic person and the administering of a local anesthesia by a dentist. Disposable syringes are favored over reusable syringes for vaccines, in order to avoid the risk of transmitting blood-borne diseases such as human immunodeficiency virus (HIV) and hepatitis from one person to another. Disposable syringes also are used to inject anesthetics for medical procedures. They can be used either alone or in combination with anesthetic gas for general anesthesia. They can be used in combination with anesthetic spray or cream for local anesthesia. The syringes used by dentists to administer local anesthesia before drilling or pulling teeth are a common example. Disposable syringes sometimes are used for drawing blood samples. They allow greater precision than evacuated tube systems, so syringes used together with butterfly needles often are favored when drawing blood. Market Survey The Indian healthcare sector, including pharmaceutical, diagnostics and hospital services, is expected to more than double its revenues to Rs 2500 bn by 2014. Expenditure on healthcare services, including diagnostics, hospital occupancy and outpatient consulting, the largest component of this spend is expected to grow more than 125% to Rs 1560 bn. The Indian domestic Medicare devices industry is expected to grow from Rs 60 bn to Rs 76.5 bn in four years. The overall market is estimated at Rs 150 bn. A major part of the demand is met through imports. Devices, such as catheters and stents represent nearly two-fifth of the entire range of diagnostic devices and most critical as per international classification. Presently medical devices are treated like drugs and regulated by state drug regulators under the drug law - Drugs and Cosmetics Act. Guidelines would make it mandatory for producers to get their products certified by notified bodies like ISO and BIS. The market for non-premium equipments, appliances and disposables is, however, dominated by the domestic manufacturers, while foreign suppliers and Indian companies with foreign alliances dominate the high-end hi-tech medical equipment and appliances. With the healthcare sector being opened up to private players, India is now emerging as a lucrative market for global firms dealing in hi-tech diagnostic and imaging equipment. In the Indian single uses syringes market, which is nearly 1.5 bn units strong, Hindustan Syringes and Medical Devices (HMD) enjoys a 65% market share. Imports constitute 10% of this market. In the single use needles market, HMD has a 70% market share, followed by imported brands with a 25% market share. The size of the local needles market is 2.5 bn units per annum. With the opening of healthcare sector, the market for medical equipment and accessories has become more vibrant. A large number of new medical facilities have been created by a large numbers of service providers, which is indicative of the great potential for medical equipment in India. The Indian market is expanding in all directions as a result of better affordability, greater health consciousness and expanding medical service institutions. With a population of 1.15 bn, India will need to at least 2 mn beds in the next 10 years in order to attain a modest target of 2 per 1000 of population. With a total healthcare value of USD 400 bn, the potential for Medicare equipment is, indeed large. Although there is a large untapped potential, the industry is confronted with problems of low volumes, high cost of production/operation, and rapid obsolescence as a result of accelerated, almost continuous, technological breakthroughs. The fragmentation of production facilities forestalls any worthwhile effort at R&D. This leads to industry's dependence on imported technology. Nonetheless, it is crystal clear that with the fast commercialization process of the sector and upgradation of medical facilities, the potential is sky-high. Few Major Players are listed below: Albert David Ltd. Disposable Medi-Aids Ltd. H L L Lifecare Ltd. Hindustan Syringes & Medical Devices Ltd. Iscon Surgicals Ltd. La Medical Devices Ltd. Lifeline Injects Ltd. Lifelong Meditech Ltd. Nirma Ltd. Raaj Medisafe India Ltd. Sangam Health Care Products Ltd. Surgiplast Ltd.
Plant capacity: 180 Lakh Nos. /annumPlant & machinery: 245 Lakhs
Working capital: -T.C.I: Cost of Project: 455 Lakhs
Return: 26.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Copper Sulphate - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Layout

Copper (II) Sulfate is a chemical compound with the formula CuSO4. It occurs in nature as mineral hydrocyanite. It is gray to white and has rhombic crystal morphology. It decomposes to green basic copper (II) sulphate at 340 deg C and at 600-650 deg C it decomposes to copper oxide. It is generally prepared by controlled heating of Copper Sulphate Pent-hydrate, CuSO4.5H2O. Copper sulphate term is generally used to describe pent hydrate compound of copper sulphate which is also known as blue stone, blue vitriol etc. It is best known and the most widely used of the copper salts. Indeed it is often the starting raw material for the production of many of the other copper salts. Today the world's consumption is around 250,000 tons per annum of which it is estimated that approximately three-quarters are used in agriculture, principally as a fungicide. Uses & Application Anhydrous Copper sulphate has limited commercial use. • It is used as a desiccant for removing water from organic solvents. • It acts as a sensitive indicator of the presence of moisture in organic solvents. Copper sulphate pentahydrate is a very versatile chemical with as extensive a range of uses in industry. • It is used as an algaecide, an herbicide in irrigation and municipal water treatment systems, and as a molluscicide, a material used to repel and kill slugs and snails. • The metal industry uses large quantities of copper sulphate as an electrolyte in copper refining, for copper coating steel wire prior to wire drawing and in various copper plating processes. • The mining industry employs it as an activator in the concentration by froth flotation of lead, zinc, cobalt and gold ores. • The printing trade takes it as an electrolyte in the production of electrotype and as an etching agent for process engraving. • The paint industry uses it in anti-fouling paints and it plays a part in the coloring of glass. • Copper sulphate is a fungicide used to control bacterial and fungal diseases of fruit, vegetable, nut and field crops. It is used in combination with lime and water as a protective fungicide, referred to as Bordeaux mixture, for leaf application and seed treatment. • Copper deficiency in plants or animals can be corrected very simply either by applying 50 kg copper sulphate per hectare in the form of a fertilizer before sowing or by spraying the foliage of the young cereal plants. Market Survey The Market Survey on Copper Sulphate is of topical interest in the sense that copper is important metal used in India from ancient times. In fact, one age of human civilization is named after copper. Copper is also used in the alloy form as brass and bronze because of the added advantages. Copper was a scarce metal with respect to India but recent setting up of copper smelters has entirely changed the scenario of copper production/availability in the country. However, these copper smelters, except that of HCL, are producing copper based on the imported concentrates. This has opened a new path for the chemical manufacturing companies for producing copper based chemicals in the country. With numerous copper mines in the country, Copper compounds manufacturing has taken a good shot in last few years. Many Companies are setting their projects at different places in India. They produce environment friendly copper sulphate fertilizer, Copper Sulphate Electroplating Grade, Copper Sulphate Feed grade having 98% Copper content. Copper sulphate is widely used as fungicide in agricultural field. Therefore demand of copper sulphate directly depends upon the usage and development of agriculture in a country. In India, the total installed annual capacity of 43 technical grades of pesticides and fungicide is estimated at 148,000 tonnes of which only four grades (Mancozab 20,700 tonnes, Monocrotophos 14,000 tonnes, Malathion 11,800 tonnes and Endo-sulphan 10,100 tonnes) account for over 38% of the aggregate installed capacities. ? India is one among the most dynamic generic pesticides & fungicides manufacturing countries. And yet, India's own average consumption of it is low, below 500 gms per ha. Crop protection has assumed special importance since the food grains demand in the country is supposed to reach an estimated 343 mn tonnes by 2020. The agrochemical industry allocates an average of about 10% of its total sales turnover for research and development. This amounts to Rs 3.5-4.0 bn. The agrochemical industry is spread over around 200 large and medium sized manufacturers and 600 formulators producing about 60 technical grades of pesticides. Other important players in the sector include 10 multinational companies operating for quite some time. While the organized sector contributes 55% to the industry's output, the small scale sector makes up for the balance. The Indian industry has been focusing on integrated crop management (ICM), increasing exports of genuine pesticides & fungicide and concentrating on farmer-friendly activities. With the global market rising, there are encouraging prospects for the Indian industry. The pesticide industry is targeting a 10% share of global pesticides market and has been working on the ICM program to introduce safer applications, spray devices and crop protection through balanced use of biological and chemical pesticides. The exports cover pesticide intermediates. Pesticides and fungicide exports from India were growing at the rate of 15% and are expected to witness a more accelerated growth. Demand of copper sulphate is increasing rapidly for its use as a natural growth stimulant in animals, as well as in prevention of E.coli and listeria. The food-grade Copper Sulfate industry is a $1.2 billion industry growing at approximately 15% per year.
Plant capacity: 600 Nos. /annumPlant & machinery: 43 Lakhs
Working capital: -T.C.I: Cost of Project: 238 Lakhs
Return: 24.00%Break even: 60.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

It is an instrument which is used for injecting any liquid into the body of human beings or of animals. These syringes are used for injecting the medicine into the body or into the nerve of the body which are not possible to take in through mouth or takes much time in mixing with blood. A syringe is a simple piston pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (the barrel), allowing the syringe to take in and expel a liquid or gas through an orifice at the open end of the tube. The open end of the syringe may be fitted with a hypodermic needle, a nozzle, or tubing to help direct the flow into and out of the barrel. The constantly increasing use of Disposable Syringes made of plastic Material indicates its importance, which is based mainly on the advantages it offers regarding cost and hygienic applications. Due to their availability is sterilized condition, ready to use and cost effectiveness, disposable syringes are fast replacing the age-old glass syringes. Disposable syringes are mostly injection moulded from polypropylene. Syringes are available in sizes of 1ml, 2ml, and 10ml, in a variety of designs and consist of either two or three components in their material of construction. The number and size of injection moulding machines required depends upon syringe construction, number of mould cavities and annual production. Uses & Applications Disposable syringes commonly are used in modern medicine for the injection of drugs and vaccines or for the extraction of blood. Among the common uses of disposable syringes are the injecting of insulin by a diabetic person and the administering of a local anesthesia by a dentist. Disposable syringes are favored over reusable syringes for vaccines, in order to avoid the risk of transmitting blood-borne diseases such as human immunodeficiency virus (HIV) and hepatitis from one person to another. Disposable syringes also are used to inject anesthetics for medical procedures. They can be used either alone or in combination with anesthetic gas for general anesthesia. They can be used in combination with anesthetic spray or cream for local anesthesia. The syringes used by dentists to administer local anesthesia before drilling or pulling teeth are a common example. Disposable syringes sometimes are used for drawing blood samples. They allow greater precision than evacuated tube systems, so syringes used together with butterfly needles often are favored when drawing blood. Market Survey The Indian healthcare sector, including pharmaceutical, diagnostics and hospital services, is expected to more than double its revenues to Rs 2500 bn by 2014. Expenditure on healthcare services, including diagnostics, hospital occupancy and outpatient consulting, the largest component of this spend is expected to grow more than 125% to Rs 1560 bn. The Indian domestic Medicare devices industry is expected to grow from Rs 60 bn to Rs 76.5 bn in four years. The overall market is estimated at Rs 150 bn. A major part of the demand is met through imports. Devices, such as catheters and stents represent nearly two-fifth of the entire range of diagnostic devices and most critical as per international classification. Presently medical devices are treated like drugs and regulated by state drug regulators under the drug law - Drugs and Cosmetics Act. Guidelines would make it mandatory for producers to get their products certified by notified bodies like ISO and BIS. The market for non-premium equipments, appliances and disposables is, however, dominated by the domestic manufacturers, while foreign suppliers and Indian companies with foreign alliances dominate the high-end hi-tech medical equipment and appliances. With the healthcare sector being opened up to private players, India is now emerging as a lucrative market for global firms dealing in hi-tech diagnostic and imaging equipment. In the Indian single uses syringes market, which is nearly 1.5 bn units strong, Hindustan Syringes and Medical Devices (HMD) enjoys a 65% market share. Imports constitute 10% of this market. In the single use needles market, HMD has a 70% market share, followed by imported brands with a 25% market share. The size of the local needles market is 2.5 bn units per annum. With the opening of healthcare sector, the market for medical equipment and accessories has become more vibrant. A large number of new medical facilities have been created by a large numbers of service providers, which is indicative of the great potential for medical equipment in India. The Indian market is expanding in all directions as a result of better affordability, greater health consciousness and expanding medical service institutions. With a population of 1.15 bn, India will need to at least 2 mn beds in the next 10 years in order to attain a modest target of 2 per 1000 of population. With a total healthcare value of USD 400 bn, the potential for Medicare equipment is, indeed large. Although there is a large untapped potential, the industry is confronted with problems of low volumes, high cost of production/operation, and rapid obsolescence as a result of accelerated, almost continuous, technological breakthroughs. The fragmentation of production facilities forestalls any worthwhile effort at R&D. This leads to industry's dependence on imported technology. Nonetheless, it is crystal clear that with the fast commercialization process of the sector and upgradation of medical facilities, the potential is sky-high. Few Major Players are listed below: Albert David Ltd. Disposable Medi-Aids Ltd. H L L Lifecare Ltd. Hindustan Syringes & Medical Devices Ltd. Iscon Surgicals Ltd. La Medical Devices Ltd. Lifeline Injects Ltd. Lifelong Meditech Ltd. Nirma Ltd. Raaj Medisafe India Ltd. Sangam Health Care Products Ltd. Surgiplast Ltd.
Plant capacity: 180 Lakh Nos. /annumPlant & machinery: 245 Lakhs
Working capital: -T.C.I: Cost of Project: 455 Lakhs
Return: 26.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Copper Sulphate - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Layout

Copper Sulphate is of topical interest in the sense that copper is important metal used in India from ancient times. Copper sulphate is widely used as fungicide in agricultural field. Therefore demand of copper sulphate directly depends upon the usage and development of agriculture in a country. In India, the total installed annual capacity of 43 technical grades of pesticides and fungicide is estimated at 148,000 tonnes. The Indian industry has been focusing on integrated crop management (ICM), increasing exports of genuine pesticides & fungicide and concentrating on farmer-friendly activities. With the global market rising, there are encouraging prospects for the Indian industry. The pesticide industry is targeting a 10% share of global pesticides market and has been working on the ICM program to introduce safer applications, spray devices and crop protection through balanced use of biological and chemical pesticides. The exports cover pesticide intermediates. Pesticides and fungicide exports from India were growing at the rate of 15% and are expected to witness a more accelerated growth. Also, demand of copper sulphate is increasing rapidly for its use as a natural growth stimulant in animals, as well as in prevention of E.coli and listeria. The food-grade Copper Sulfate industry is a $1.2 billion industry growing at approximately 15% per year.
Plant capacity: 600 Nos. /annumPlant & machinery: Rs.43 Lakhs
Working capital: -T.C.I: Cost of Project:Rs.238 Lakhs
Return: 24.00%Break even: 60.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

It is an instrument which is used for injecting any liquid into the body of human beings or of animals. The Indian healthcare sector, including pharmaceutical, diagnostics and hospital services, is expected to more than double its revenues to Rs 2500 bn by 2014. The Indian domestic Medicare devices industry is expected to grow from Rs 60 bn to Rs 76.5 bn in four years. The overall market is estimated at Rs 150 bn. A major part of the demand is met through imports. With the healthcare sector being opened up to private players, India is now emerging as a lucrative market for global firms dealing in hi-tech diagnostic and imaging equipment. In the Indian single uses syringes market, which is nearly 1.5 bn units strong, Hindustan Syringes and Medical Devices (HMD) enjoys a 65% market share. Imports constitute 10% of this market. In the single use needles market, HMD has a 70% market share, followed by imported brands with a 25% market share. The size of the local needles market is 2.5 bn units per annum. It is crystal clear that with the fast commercialization process of the sector and upgradation of medical facilities, the potential is sky-high. Few Major Players are listed below: Albert David Ltd. Disposable Medi-Aids Ltd. H L L Lifecare Ltd. Hindustan Syringes & Medical Devices Ltd. Iscon Surgicals Ltd. La Medical Devices Ltd. Lifeline Injects Ltd. Lifelong Meditech Ltd. Nirma Ltd. Raaj Medisafe India Ltd. Sangam Health Care Products Ltd. Surgiplast Ltd.
Plant capacity: 180 Lakh Nos. /annumPlant & machinery: Rs.245 Lakhs
Working capital: -T.C.I: Cost of Project:Rs. 455 Lakhs
Return: 26.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit(Automatic Plant of Tablet and Capsule) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market, with market leader holding nearly 7% of the market share. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs etc. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. The domestic market is estimated at Rs 680 bn. The key categories driving growth are the traditionally largest segment - anti-infective and gastro-intestinal, drugs, which expanded by 22% and 19% respectively. Fast sales growth is also visible in categories like respiratory (18%), cardiac (14%), neurology (20%) and anti-diabetic (19%). The number of product launches exceeds 2,000 annually. Both MNC and Indian companies are implementing strategies which will help them to benefit from and cope with the developing patent regime. India has the highest number of (US Food and Drug Administration) USFDA approved manufacturing facilities outside the US and this puts India in good position to export to regulated markets. The major players in the country are: Aanjaneya Lifecare Ltd. Aashi Industries Ltd. Abbott India Ltd. Advik Laboratories Ltd. Aesculapius Remedies Ltd. Ajanta Pharma Ltd. Albert David Ltd. Alkem Laboratories Ltd. Alpa Laboratories Ltd. Ambalal Sarabhai Enterprises Ltd. Amee Cosmo Pharma Ltd. American Remedies Ltd. Amstrin Healthcare Ltd. Anan Drug & Chem Ltd. Andre Laboratories Ltd. Anglo-French Drugs & Inds. Ltd. Ankur Drugs & Pharma Ltd. Anmol Drugs & Pharmaceuticals Ltd. Anuh Pharma Ltd. Apex Laboratories Ltd. Apple Laboratories Ltd. Armour Chemicals Ltd. Arvind Remedies Ltd. Astrazeneca Pharma India Ltd. Astron Drugs & Inds. Ltd. Aurobindo Pharma Ltd. Aventis Pharma Ltd. B D H Industries Ltd. Bafna Pharmaceuticals Ltd. Bal Pharma Ltd. Basav Chem Ltd. Bassein Drugs Ltd. Beem Healthcare Ltd. Bengal Immunity Ltd. Beryl Drugs Ltd. Bharat Parenterals Ltd. Bharat Serums & Vaccines Ltd. Biddle Sawyer Ltd. Bio-Ethicals Pharma Ltd. Biocon Biopharmaceuticals Pvt. Ltd. Biocon Ltd. Biofil Chemicals & Pharmaceuticals Ltd. Biological E. Ltd. Blue Cross Laboratories Ltd. Boehringer Mannheim India Ltd. Brabourne Enterprises Ltd. Bravo Healthcare Ltd. Brawn Biotech Ltd. Burroughs Wellcome (India) Ltd. Cadila Healthcare Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Caplin Point Laboratories Ltd. Caryl Laboratories Ltd. Casil Industries Ltd. Celestial Biolabs Ltd. Centaur Pharmaceuticals Pvt. Ltd. Cepham Organics Ltd. Cepham Pharmaceuticals Ltd. Chemech Laboratories Ltd. Chemosyn Ltd. Ciba Ckd Biochem Ltd. Claris Lifesciences Ltd. Colinz Laboratories Ltd. Combat Drugs Ltd. Concept Pharmaceuticals Ltd. Concord Biotech Ltd. Concord Drugs Ltd. Coral Laboratories Ltd. Core Laboratories Ltd. Cosme Farma Laboratories Ltd. Cosme Pharma Ltd. Creative Health Care Pvt. Ltd. Croslands Research Laboratories Ltd. Croydon Chemical Works Ltd. Curewell (India) Ltd. Damania Pharma Ltd. Deepharma Laboratories Ltd. Deepharma Ltd. Dey'S Medical Stores Mfg. Ltd. Dishman Pharmaceuticals & Chemicals Ltd. Dolphin Laboratories Ltd. Dr. Reddy'S Laboratories Ltd. Druid Pharma Ltd. Dujohn Laboratories Ltd. Dumex Ltd. Eaco Labs Ltd. Earnest Healthcare Ltd. East India Pharmaceutical Works Ltd. Ebers Pharmaceuticals Ltd. Elder Health Care Ltd. Elder Pharmaceuticals Ltd. Elder Projects Ltd. Elvina Pharmaceuticals Ltd. Emaai Pharma Ltd. Emcure Pharmaceuticals Ltd. Endo Labs Ltd. Entod Pharmaceuticals Ltd. Esskay Pharmaceuticals Ltd. Ethnor Ltd. Eupharma Laboratories Ltd. Everest Organics Ltd. Evid & Co. Chemicals Ltd. F D C Ltd. Fine Drugs & Chemicals Ltd. Flamingo Pharmaceuticals Ltd. Fredun Pharmaceuticals Ltd. Fresenius Kabi Oncology Ltd. Fulford (India) Ltd. Geno Pharmaceuticals Ltd. Gentech Laboratories Ltd. Geoffrey Manners & Co. Ltd. German Remedies Ltd. Glaxosmithkline Pharmaceuticals Ltd. Glen mark Exports Ltd. Glen mark Generics Ltd. Glen mark Laboratories Ltd. Glen mark Pharmaceuticals Ltd. Global Remedies Ltd. Goa Antibiotics & Pharmaceuticals Ltd. Group Pharmaceuticals Ltd. Guardian Health Care Ltd. Gufic Biosciences Ltd. Gujarat Inject Ltd. Gujarat Terce Laboratories Ltd. Gujarat Themis Biosyn Ltd. H O D Laboratories Ltd. Hab Pharmaceuticals & Research Ltd. Haffkine Ajintha Pharmaceuticals Ltd. Hallmark Healthcare Ltd. Harleystreet Pharmaceuticals Ltd. Health Care Ltd. Hexone Pharmaceuticals Ltd. Hindustan Max-Gb Ltd. Hub Pharmaceuticals Pvt. Ltd. I D P L (Tamil Nadu) Ltd. Icon Biopharma & Healthcare Ltd. Icpa Health Products Ltd. Idma Laboratories Ltd. Ind-Swift Laboratories Ltd. Ind-Swift Ltd. India Infusion Ltd. Indian Drugs & Pharmaceuticals Ltd. Indoco Healthcare Ltd. Indoco Remedies Ltd. Indon Healthcare Ltd. Innotech Pharma Ltd. Intas Pharmaceuticals Ltd. Intercare Limited Intercare Ltd. International Drug Co. Ltd. Inventia Healthcare Pvt. Ltd. Inwinex Pharmaceuticals Ltd. Ipca Laboratories Ltd. Ivee Injectaa Ltd. J B Chemicals & Pharmaceuticals Ltd. J K Pharmachem Ltd. Jagsonpal Exports India Pvt. Ltd. Jagsonpal Pharmaceuticals Ltd. Jenburkt Pharmaceuticals Ltd. Jilichem Laboratories (India) Ltd. John Wyeth (India) Ltd. Johnson & Johnson Ltd. Kabra Drugs Ltd. Kappac Pharma Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd. Kee Pharma Ltd. Kilitch Drugs (India) Ltd. Konkan Capsules Ltd. Krebs Biochemicals & Inds. Ltd. Labinduss Ltd. Lekar Healthcare Ltd. Lekar Pharma Ltd. Lincoln Pharmaceuticals Ltd. Liva Healthcare Ltd. Lordvin Labs Ltd. Lupin Laboratories Ltd. Lupin Ltd. Lyka B D R International Ltd. Lyka Labs Ltd. Lympha Laboratories Ltd. M J Pharmaceuticals Ltd. Macleods Pharmaceuticals Ltd. Maharashtra Antibiotics & Pharmaceuticals Ltd. Makers Laboratories Ltd. Maneesh Pharmaceuticals Ltd. Manipur State Drugs & Pharmaceuticals Ltd. Marck Biosciences Ltd. Mars Life Sciences Ltd. Martin & Harris Laboratories Ltd. Max India Ltd. Mayank & Lili Pharma Ltd. Mayo (India) Ltd. Mcneil & Argus Pharmaceuticals Ltd. Medicamen Biotech Ltd. Medispan Ltd. Medley Pharmaceuticals Ltd. Meghdoot Chemicals Ltd. Meher Pharma (India) Ltd. Merck Ltd. Mercury Laboratories Ltd. Mercury Phytochem Ltd. Merind Ltd. Mesco Pharmaceuticals Ltd. Metropolitan Overseas Ltd. Micro Labs Ltd. Monarch Laboratories Ltd. Morepen Laboratories Ltd. Mount Mettur Pharmaceuticals Ltd. N B Z Pharma Ltd. N R Jet Enterprises Ltd. Natco Pharma Ltd. Nem Organics Ltd. Neon Laboratories Ltd. Nestor Pharmaceuticals Ltd. Neulife Laboratories Ltd. Nirma Ltd. Nitya Laboratories Ltd. Novartis India Ltd. Novus Pharmaceuticals Ltd. Om Pharmaceuticals Ltd. Omega Biotech Ltd. Omega Laboratories Ltd. Onco Therapies Ltd. Opec Innovations Ltd. Orchid Chemicals & Pharmaceuticals Ltd. Organon (India) Ltd. Ozone Pharmaceuticals Ltd. P C I Chemicals & Pharmaceuticals Ltd. Paam Pharmaceuticals (Delhi) Ltd. Panacea Biotec Ltd. Parabolic Drugs Ltd. Paras Pharmaceuticals Ltd. Parke-Davis (India) Ltd. Penam Laboratories Ltd. Perk Pharmaceuticals Ltd. Pfimex Pharmaceuticals Ltd. Pfizer Ltd. Phaarmasia Ltd. Phar-East Laboratories Ltd. Pharmacia Healthcare Ltd. Pharmaids Pharmaceuticals Ltd. Pharmax Corporation Ltd. Pharmed Ltd. Phyto Specialities Pvt. Ltd. Plethico Pharmaceuticals Ltd. Procter & Gamble Hygiene & Health Care Ltd. Quality Pharmaceuticals Ltd. R P G Life Sciences Ltd. Rajasthan Drugs & Pharmaceuticals Ltd. Rajat Pharmachem Ltd. Ranbaxy Drugs Ltd. Ranbaxy Laboratories Ltd. Raptakos, Brett & Co. Ltd. Ravish Infusions Ltd. Reckitt Benckiser (India) Ltd. Rekvina Laboratories Ltd. Resonance Specialties Ltd. Rhone-Poulenc (India) Ltd. Rolex Pharmaceuticals Ltd. Rosemount Pharma India Ltd. Rubra Medicaments Ltd. Rupal Chemical Inds. Ltd. Rusan Pharma Ltd. S A M Biotech Ltd. Saket Projects Ltd. Sandoz (India) Ltd. [Amalgamated] Sanjeevanee Pharmaceuticals Ltd. Sanjivani Paranteral Ltd. Sanofi-Synthelabo (India) Ltd. Sarabhai Piramal Pharmaceuticals Pvt. Ltd. Sarala Pharmaceuticals Ltd. Sarthi Pharmaceuticals Ltd. Sarvodaya Labs Ltd. Schering-Plough (India) Pvt. Ltd. Senbo Industries Ltd. Shalina Laboratories Pvt. Ltd. Sharvani Pharmaceuticals Ltd. Shiv Herbal Research Laboratory Ltd. Sidmak Laboratories (India) Pvt. Ltd. Sigma Laboratories Ltd. Smith Stanistreet Pharmaceuticals Ltd. Smithkline Beecham Pharmaceuticals (India) Ltd. [Amalgamated] Solumiks Herbaceuticals Ltd. Sri Chakra Remedies Ltd. Sri Krishna Drugs Ltd. Sri Krishna Pharmaceuticals Ltd. Strides Arcolab Ltd. Sun Pharmaceutical Inds. Ltd. Surya Pharmaceutical Ltd. Sustime Pharma Ltd. Suyog Pharmaceuticals Pvt. Ltd. Swega Laboratories Ltd. Swet-Chem Antibiotics Ltd. Syncom Formulations (India) Ltd. Syncom Healthcare Ltd. T K Healthcare Ltd. Tablets (India) Ltd. Tamilnadu Dadha Pharmaceuticals Ltd. Targof Pure Drugs Ltd. Taulis Pharma Ltd. Teem Laboratories Ltd. Themis Medicare Ltd. Tonira Pharma Ltd. Torrent Pharmaceuticals Ltd. Toshvin Industries Ltd. Trans Medicare Ltd. Travel Co. In Pvt. Ltd. Troika Pharmaceuticals Ltd. Twilight Litaka Pharma Ltd. U S V Ltd. Uni-Sankyo Ltd. Uni-Ucb Ltd. Unibios Laboratories Ltd. Unichem Laboratories Ltd. Unicorn Pharmaceuticals (India) Ltd. Unimark Remedies Ltd. Unimed Investments Ltd. Unimed Technologies Ltd. Unique Pharmaceutical Laboratories Ltd. Universal Generics Ltd. Universal Pharmaceuticals Ltd. Unjha Formulations Ltd. Vellanova Pharmaceuticals Ltd. Venkat Pharma Ltd. Veronica Laboratories Ltd. Vista Pharmaceuticals Ltd. Vita Biopharma Pvt. Ltd. Vysali Pharmaceuticals Ltd. Wallace Pharmaceuticals Ltd. Wander Pvt. Ltd. Warren Pharmaceuticals Ltd. Welcure Drugs & Pharmaceuticals Ltd. White Way Products (Pharma) Ltd. Win-Medicare Pvt. Ltd. Wintac Ltd. Wockhardt’s Ltd. Wyeth Laboratories Ltd. Wyeth Ltd. Yogi Healthcare Ltd. Zenith Health Care Ltd. Zenotech Laboratories Ltd. Zillion Pharmachem Ltd. Zim Laboratories Ltd. Zuventus Healthcare Ltd. Zydus Animal Health Ltd. Zydus Pathline Ltd.
Plant capacity: 117 Lakhs Nos. /annumPlant & machinery: Rs. 125 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 1340 Lakhs
Return: 43.47%Break even: 54.86%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 11 of 35 | Total 346 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 34 35   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top